PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION OF THE FIRST-IN-CLASS SELECTIVE SIK2/SIK3 INHIBITOR GLPG3970 IN EXPERIMENTAL MODELS OF IBD
Anna Pereira-Fernandes 1
Stéphanie Lavazais 2
Carole Delachaume 2
Michael Drennan 2
Didier Merciris 2
Nancy Agten 2
Christophe Peixoto 2
Anne Gigout 2
Nicolas Desroy 2
David AMANTINI 2
Steve De Vos 2
1 Galapagos NV, Mechelen, Belgium
2 Galapagos SASU, Romainville, France
Topic
Disease Mechanisms, IBD, Immunology
Session
Basic science in IBD
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]